Name: Thalassemia Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMMD1276
Price: 4350 USD
Availability: InStock

Thalassemia Market Size Share Growth Opportunities and Forecast 2022

Thalassemia Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Thalassemia Market is segmented&nbsp;By Disease Type (Alpha Thalassemia, Beta Thalassemia),&nbsp;By Treatment Type (Blood Transfusion, Iron Chelation Therapy, Bone Marrow Transplant, Gene Therapy, Surgery),&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global &quot;Thalassemia Market&quot;&nbsp;is expected to grow at a high&nbsp;<a href="https://www.datamintelligence.com/download-sample/thalassemia-market">CAGR</a>&nbsp;during the forecasting period (2022-2029).
</blockquote>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/thalassemia-treatment-market">Thalassemia Treatment Market</a>

<a href="https://www.datamintelligence.com/research-report/achalasia-treatment-market">Achalasia Treatment Market</a>

<a href="https://www.datamintelligence.com/research-report/poems-syndrome-market">POEMS Syndrome Market</a>

<h3>&nbsp;</h3>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

1. Methodology and Scope

1.1. Research Methodology

1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

3.1.&nbsp;Market Snippet by Disease Type

3.2. Market Snippet by Treatment Type

3.3. Market Snippet by Region

3.4. DataM CLO Scenario

4. Market Dynamics

4.1. Market Impacting Factors

4.1.1. Drivers

4.1.1.1. Rising prevalence of thalassemia

4.1.1.2. Surge in research and development

4.1.1.3. Rise in public awareness

4.1.2. Restraints

4.1.2.1. Side effects caused by drugs

4.1.3. Opportunity

4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter&#39;s Five Forces Analysis

5.2. Supply Chain Analysis

5.3. Regulatory Analysis

5.4. Epidemiology

6. Pipeline Analysis

7. By Disease Type

7.1. Introduction

7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

7.3. Market Attractiveness Index, By Disease Type

7.4.&nbsp;Alpha Thalassemia

7.4.1. Introduction

7.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

7.5.&nbsp;Beta Thalassemia

8. By Treatment Type

8.1. Introduction

8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type

8.3.&nbsp;Market Attractiveness Index, By Treatment Type

8.4. Blood Transfusion

8.4.1. Introduction

8.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

8.5.&nbsp;Iron Chelation Therapy

8.6. Bone Marrow Transplant

8.7. Gene Therapy

8.8. Surgery

9. By Region

9.1. Introduction

9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

9.3. Market Attractiveness Index, By Region

9.4. North America

9.4.1. Introduction

9.4.2. Key Region-Specific Dynamics

9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.4.5.1. U.S.

9.4.5.2. Canada

9.4.5.3. Mexico

9.5. Europe

9.5.1. Introduction

9.5.2. Key Region-Specific Dynamics

9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.5.5.1. Germany

9.5.5.2. U.K.

9.5.5.3. France

9.5.5.4. Italy

9.5.5.5. Spain

9.5.5.6. Rest of Europe

9.6. South America

9.6.1. Introduction

9.6.2. Key Region-Specific Dynamics

9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.6.5.1. Brazil

9.6.5.2. Argentina

9.6.5.3. Rest of South America

9.7. Asia Pacific

9.7.1. Introduction

9.7.2. Key Region-Specific Dynamics

9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.7.5.1. China

9.7.5.2. India

9.7.5.3. Japan

9.7.5.4. Australia

9.7.5.5. Rest of Asia Pacific

9.8. Middle East and Africa

9.8.1. Introduction

9.8.2. Key Region-Specific Dynamics

9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

10. Global Market &ndash; Competitive Landscape

10.1. Competitive Scenario

10.2. Competitor Thalassemia Strategy Analysis

10.3. Comparative Product Portfolio Analysis

10.4. Market Positioning/Share Analysis

10.5. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Incyte Corporation *

11.1.1. Company Overview

11.1.2. Product Portfolio and Description

11.1.3. Key Highlights

11.1.4. Financial Overview

11.2. Kiadis Pharma

11.3. Gamida Cell

11.4. Bellicum Pharmaceuticals

11.5. Bluebird Bio

11.6. Novartis

11.7. Celgene Corporation

11.8. Lonza Group Ltd.

11.9. Sangamo Bioscience

11.10. Acceleron Pharma, Inc.

12. DataM Intelligence

12.1. Appendix

12.2. About Us and Services

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

&nbsp;List of Tables

Table 1 Global Thalassemia Market Value, By Disease Type, 2021,2025 &amp; 2029 ($ Million)

Table 2 Global Thalassemia Market Value, By Treatment Type, 2021,2025 &amp; 2029 ($ Million)

Table 3 Global Thalassemia Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 4 Global Thalassemia Market Value, By Disease Type, 2021,2025 &amp; 2029 ($ Million)

Table 5 Global Thalassemia Market Value, By Disease Type, 2017-2029 ($ Million)

Table 6 Global Thalassemia Market Value, By Treatment Type, 2021,2025 &amp; 2029 ($ Million)

Table 7 Global Thalassemia Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 8 Global Thalassemia Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 9 Global Thalassemia Market Value, By Region, 2017-2029 ($ Million)

Table 10 North America Thalassemia Market Value, By Disease Type, 2017-2029 ($ Million)

Table 11 North America Thalassemia Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 12 North America Thalassemia Market Value, By Country, 2017-2029 ($ Million)

Table 13 South America Thalassemia Market Value, By Disease Type, 2017-2029 ($ Million)

Table 14 South America Thalassemia Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 15 South America Thalassemia Market Value, By Country, 2017-2029 ($ Million)

Table 16 Europe Thalassemia Market Value, By Disease Type, 2017-2029 ($ Million)

Table 17 Europe Thalassemia Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 18 Europe Thalassemia Market Value, By Country, 2017-2029 ($ Million)

Table 19 Asia-Pacific Thalassemia Market Value, By Disease Type, 2017-2029 ($ Million)

Table 20 Asia-Pacific Thalassemia Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 21 Asia-Pacific Thalassemia Market Value, By Country, 2017-2029 ($ Million)

Table 22 Middle East &amp; Africa Thalassemia Market Value, By Disease Type, 2017-2029 ($ Million)

Table 23 Middle East &amp; Africa Thalassemia Market Value, By Treatment Type, 2017-2029 ($ Million)

Table 24 Incyte Corporation: Overview

Table 25 Incyte Corporation: Product Portfolio

Table 26 Incyte Corporation: Key Developments

Table 27 Kiadis Pharma: Overview

Table 28 Kiadis Pharma: Product Portfolio

Table 29 Kiadis Pharma: Key Developments

Table 30 Gamida Cell: Overview

Table 31 Gamida Cell: Product Portfolio

Table 32 Gamida Cell: Key Developments

Table 33 Bellicum Pharmaceuticals: Overview

Table 34 Bellicum Pharmaceuticals: Product Portfolio

Table 35 Bellicum Pharmaceuticals: Key Developments

Table 36 Bluebird Bio: Overview

Table 37 Bluebird Bio: Product Portfolio

Table 38 Bluebird Bio: Key Developments

Table 39 Novartis: Overview

Table 40 Novartis: Product Portfolio

Table 41 Novartis: Key Developments

Table 42 Celgene Corporation: Overview

Table 43 Celgene Corporation: Product Portfolio

Table 44 Celgene Corporation: Key Developments

Table 45 Lonza Group Ltd.: Overview

Table 46 Lonza Group Ltd.: Product Portfolio

Table 47 Lonza Group Ltd.: Key Developments

Table 48 Sangamo Bioscience: Overview

Table 49 Sangamo Bioscience: Product Portfolio

Table 50 Sangamo Bioscience: Key Developments

Table 51 Acceleron Pharma, Inc.: Overview

Table 52 Acceleron Pharma, Inc.: Product Portfolio

Table 53 Acceleron Pharma, Inc.: Key Developments

&nbsp;

List of Figures

Figure 1 Global Thalassemia Market Share, By Disease Type, 2021 &amp; 2029 (%)

Figure 2 Global Thalassemia Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 3 Global Thalassemia Market Share, By Region, 2021 &amp; 2029 (%)

Figure 4 Global Thalassemia Market Value, 2017-2029 ($ Million)

Figure 5 Global Thalassemia Market Y-o-Y Growth, By Disease Type, 2021-2029 (%)

Figure 6 Alpha Thalassemia: Global Thalassemia Market Value, 2017-2029 ($ Million)

Figure 7 Beta Thalassemia: Global Thalassemia Market Value, 2017-2029 ($ Million)

Figure 8 Global Thalassemia Market Y-o-Y Growth, By Treatment Type, 2021-2029 (%)

Figure 9 Blood Transfusion: Global Thalassemia Market Value, 2017-2029 ($ Million)

Figure 10 Iron Chelation Therapy: Global Thalassemia Market Value, 2017-2029 ($ Million)

Figure 11 Bone Marrow Transplant: Global Thalassemia Market Value, 2017-2029 ($ Million)

Figure 12 Gene Therapy: Global Thalassemia Market Value, 2017-2029 ($ Million)

Figure 13 Surgery: Global Thalassemia Market Value, 2017-2029 ($ Million)

Figure 14 Global Thalassemia Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 15 North America Thalassemia Market Value, 2017-2029 ($ Million)

Figure 16 North America Thalassemia Market Share, By Disease Type, 2021 &amp; 2029 (%)

Figure 17 North America Thalassemia Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 18 North America Thalassemia Market Share, By Country, 2021 &amp; 2029 (%)

Figure 19 South America Thalassemia Market Value, 2017-2029 ($ Million)

Figure 20 South America Thalassemia Market Share, By Disease Type, 2021 &amp; 2029 (%)

Figure 21 South America Thalassemia Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 22 South America Thalassemia Market Share, By Country, 2021 &amp; 2029 (%)

Figure 23 Europe Thalassemia Market Value, 2017-2029 ($ Million)

Figure 24 Europe Thalassemia Market Share, By Disease Type, 2021 &amp; 2029 (%)

Figure 25 Europe Thalassemia Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 26 Europe Thalassemia Market Share, By Country, 2021 &amp; 2029 (%)

Figure 27 Asia-Pacific Thalassemia Market Value, 2017-2029 ($ Million)

Figure 28 Asia-Pacific Thalassemia Market Share, By Disease Type, 2021 &amp; 2029 (%)

Figure 29 Asia-Pacific Thalassemia Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 30 Asia-Pacific Thalassemia Market Share, By Country, 2021 &amp; 2029 (%)

Figure 31 Middle East &amp; Africa Thalassemia Market Value, 2017-2029 ($ Million)

Figure 32 Middle East &amp; Africa Thalassemia Market Share, By Disease Type, 2021 &amp; 2029 (%)

Figure 33 Middle East &amp; Africa Thalassemia Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 34 Incyte Corporation: Financials

Figure 35 Kiadis Pharma: Financials

Figure 36 Gamida Cell: Financials

Figure 37 Bellicum Pharmaceuticals: Financials

Figure 38 Bluebird Bio: Financials

Figure 39 Novartis: Financials

Figure 40 Celgene Corporation: Financials

Figure 41 Lonza Group Ltd.: Financials

Figure 42 Sangamo Bioscience: Financials

Figure 43 Acceleron Pharma, Inc.: Financials